Tag Archives: eps

Useful information for Community Pharmacists on the Prescription Tracker

Can’t find a prescription?

We’ve had feedback that patients feel like they’re “caught in the crossfire” when an electronic prescribing goes missing and they feel like they get bounced between the practice and the pharmacy.

The prescription tracker should be the solution to this problem:

Before you contact the GP practice or send the patient back to the surgery, remember you can now use the prescription tracker to search for an electronic prescription.  The prescription tracker allows you to check the status and history of electronic prescriptions.

If the prescription cannot be found, then at that point please contact the GP Practice.

The most up to date information on the prescription tracker can be found on the NHS Digital website:

https://digital.nhs.uk/electronic-prescription-service/rx-tracker

There is also useful information on the PSNC website at,

http://psnc.org.uk/dispensing-supply/eps/dispensing-in-eps-release-2/retrieving-eps-scripts/eps-prescription-tracker/

but for the latest information on the prescription tracker, please refer to the NHS Digital website as this has the latest information.

Both community pharmacies and GP practices access the same prescription tracker.

NHS Digital Prescription Tracker Factsheet for Dispensers

Electronic repeat dispensing toolkit

Electronic repeat dispensing (eRD) is an integral part of EPS, which offers many extra benefits over paper repeat dispensing and repeat prescribing.

  • two-thirds of prescriptions issued in primary care are repeat prescriptions. These repeat prescriptions account for nearly 80 per cent of NHS medicine costs for primary care
  • 410 million repeat prescriptions are generated every year – equivalent to an average of more than 375 per GP per week
  • it’s estimated that up to 330 million, or 80 per cent, of all repeat prescriptions could eventually be replaced with eRD
  • this could save 2.7 million hours of GP and practice time

NHS Digital have recently published an Electronic Repeat Dispensing Toolkit, available at https://digital.nhs.uk/article/913/Electronic-repeat-dispensing-for-prescribers which contains useful tools.  You can also sign up for some eRD webinars to find out more.

The toolkit includes an e-learning package, developed by NECS in conjunction with NHS Digital which can also be accessed through the NECS Medicines website https://medicines.necsu.nhs.uk/education-training/erd-elearning/ 

Changes in controlled drug legislation for temazepam and electronic prescribing system (EPS)

From 1st June 2015

The current prescription writing exemption applicable to temazepam prescriptions will cease and therefore all temazepam prescriptions will be required to meet full prescription writing requirements as for any other Schedule 2 or 3 controlled drugs.

Prescription requirements:

  • The quantity prescribed must be written in words and figures, e.g. 28 (twenty eight)
  • The quantity should not exceed 30 days’ supply, unless in exceptional circumstances (as with all other controlled drugs).
  • The prescription must clearly state the form (e.g. tablets, capsules), strength and dose. The dose must be as specific as possible; ‘Take one as directed’ is acceptable however ‘Take as directed’ is not.
  • Any instalment directions (on an FP10MDA prescription) must include the amount to be supplied and the interval to be observed between supplies, e.g. Supply 7 tablets every Monday

We understand that the necessary changes to practice computer systems will be made remotely by the system suppliers. We are also seeking details with respect to how pharmacies will be advised to process any temazepam prescriptions written in advance of 1st June 2015 (any relevant further information will follow).

Further information can be obtained from the following link:

http://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/parliament-approves-changes-to-regulations-governing-controlled-drugs/20068329.article

From 1st July 2015

Although the regulations will be amended to permit the electronic prescribing of Schedule 2 and 3 controlled drugs where Electronic Prescribing System (EPS) is used, the current EPS message format cannot support the inclusion of words and figures and this will therefore require a change to the EPS specification. Once this work is completed, prescribing and dispensing system suppliers will be able to make the necessary technical adjustments to their software to enable electronic transfer of Schedule 2 and 3 controlled drugs. Further updates will follow in due course.